Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 2/20 | 0.47 |
| ▸ | ALB | P02768 | 2/20 | 0.47 |
| ▸ | CA2 | P00918 | 3/20 | 0.45 |
| ▸ | CA1 | P00915 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 5/20 | 0.44 |
| ▸ | MAPT | P10636 | 5/20 | 0.44 |
| ▸ | MEN1 | O00255 | 5/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.44 |
| ▸ | TSHR | P16473 | 3/20 | 0.44 |
| ▸ | BLM | P54132 | 3/20 | 0.44 |
| ▸ | RGS12 | O14924 | 2/20 | 0.44 |
| ▸ | GMNN | O75496 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3578249 | 0.90 | CA2 (0.56) | TTRALBCA2CA1SMN1; SMN2 | |
| SCHEMBL10766961 | 0.81 | MEN1 (0.64) | TTRALBCA2CA1SMN1; SMN2 | |
| SCHEMBL10765819 | 0.81 | TTR (0.70) | TTRALBCA2CA1SMN1; SMN2 | |
| SCHEMBL6888576 | 0.78 | MEN1 (0.50) | TTRALBCA2CA1SMN1; SMN2 | |
| SCHEMBL4168959 | 0.78 | MEN1 (0.56) | TTRALBCA2CA1SMN1; SMN2 | |
| SCHEMBL5368308 | 0.78 | ALDH1A1 (0.57) | TTRALBCA2SMN1; SMN2ALDH1A1 | |
| SCHEMBL29437966 | 0.78 | ALDH1A1 (0.57) | TTRALBCA2SMN1; SMN2ALDH1A1 | |
| SCHEMBL2154631 | 0.76 | KIF11 (0.40) | TTRALBCA2CA1SMN1; SMN2 | |
| SCHEMBL18587383 | 0.76 | ALDH1A1 (0.48) | TTRALBCA2SMN1; SMN2ALDH1A1 | |
| SCHEMBL2153658 | 0.74 | KIF11 (0.39) | TTRALBCA2CA1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11040987-B2 | Penam derivatives for treating bacterial infections | TENNOR THERAPEUTICS LIMITED (CN) | 2021-06-22 | — | — | US | disclosed |
| US-6693062-B2 | LIGHT INSENSITIVE ORGANIC SILVER SALTS, REDUCING AGENTS AND 1,2-DIHYDROXYBENZENE DERIVATIVE | AGFA-GEVAERT (BE) | 2004-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11040987-B2 | Penam derivatives for treating bacterial infections | BPGM, BLVRB, PREP | TTR 3245/4885ALB 525/4885CA2 3056/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.